Mark J. Levin - 10 Nov 2021 Form 4 Insider Report for Fulcrum Therapeutics, Inc. (FULC)

Reporting relationship: Director, 10%+ Owner
Issuer ticker: FULC
Reported as of: 10 Nov 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 12 Nov 2021, 16:31:37 UTC
Prior SEC filing: 24 Sep 2021
Source filing: View source filing
Reporting owner signature: /s/ Mark Levin

Key filing fact

Mark J. Levin filed Form 4 for Fulcrum Therapeutics, Inc. (FULC) on 12 Nov 2021.

Key facts

This page summarizes Mark J. Levin's Form 4 filing for Fulcrum Therapeutics, Inc. (FULC).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 12 Nov 2021, 16:31.

Change

Previous filing in this sequence was filed on 24 Sep 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

FULC transaction

Common Stock

Other

Transaction value
Shares: -1,000,000
Change %: -20%
Price
Shares after: 3,962,202
Date: 10 Nov 2021
Ownership: See footnote
Footnotes: F1, F2

FULC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 0
Date: 10 Nov 2021
Ownership: See footnote
Footnotes: F3

FULC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 75,800
Date: 10 Nov 2021
Ownership: Direct
Footnotes: F4

FULC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 8,423
Date: 10 Nov 2021
Ownership: See footnote
Footnotes: F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Pursuant to a 10b5-1 trading plan adopted on September 8, 2021 by Third Rock Ventures III, L.P. ("TRV III"), TRV III distributed for no consideration, 1,000,000 shares of Common Stock of the Issuer (the "Shares") on November 10, 2021, to its limited partners and to Third Rock Ventures GP III, L.P. ("TRV GP III"), the general partner of TRV III, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP III distributed, for no consideration, the Shares it received in the distribution by TRV III to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended.

Footnote F2

The Reporting Person is a partner of TRV GP III, which is the general partner of TRV III. The Reporting Person disclaims beneficial ownership over the shares held by TRV III, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such shares.

Footnote F3

Third Rock Ventures IV, L.P. ("TRV IV") directly holds 2,343,154 shares. The general partner of TRV IV is Third Rock Ventures GP IV, L.P. ("TRV GP IV"). The general partner of TRV GP IV is TRV GP IV, LLC ("TRV GP IV LLC"). The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares. TRV III and TRV IV disclaim the existence of a Section 13(d) "group" as between any TRV III related parties and any TRV IV related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties.

Footnote F4

The shares are directly held by the Reporting Person. Includes Shares received in the distributions described in footnote (1) above.

Footnote F5

The shares are directly held by the Levin Family 2014 Irrevocable Trust. Includes Shares received in the distributions described in footnote (1) above.